Autor: |
Seligman R; Faculdade de Medicina da Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Departamento de Medicina Interna, Porto Alegre/RS, Brazil. reseligman@hcpa.ufrgs.br, Ramos-Lima LF, Oliveira Vdo A, Sanvicente C, Pacheco EF, Dalla Rosa K |
Jazyk: |
angličtina |
Zdroj: |
Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2012 Nov; Vol. 67 (11), pp. 1321-5. |
DOI: |
10.6061/clinics/2012(11)17 |
Abstrakt: |
Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biological and clinical features of biomarkers in CAP patients, including procalcitonin, C-reactive protein, copeptin, pro-ANP (atrial natriuretic peptide), adrenomedullin, cortisol and D-dimers. |
Databáze: |
MEDLINE |
Externí odkaz: |
|